Effects of oral and intramuscular use of chondroitin sulfate in induced equine aseptic arthritis

Journal of Equine Veterinary Science

Volumn 18, Issue 9, 1998, Pages 548-555

  Videla Dorna, I ^a,b   Guerrero, R C ^c  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b Syntex SA Prayones Avellaneda L   (Argentina)

^c NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032387180     PISSN: 07370806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0737-0806(98)80079-8     Document Type: Review

References (22)

1. Mc Ilwraith W: Current concepts in equine degenerative joint disease. J Am Vet Med Assoc 1982;180:239-250.
2. Mc Kay-Smith MP: Pathogenesis and pathology of equine osteoarthritis, J Am Vet Med Assoc 1962;141:1246-1248.
3. Hamm D, et al.: Polysulphated glycosaminoglycan: a new intra-articular treatment for equine lameness. Vet Med 1984;6:811-816.
4. Auer JA, et al.: Effect of Hyaluronic Acid in Naturally occurring and experimentally induced osteoarthritis. J Am Vet Res 1980;41(4):568-574.
5. Collins EA: Use of polysulphated glycosaminoglycan in equine lameness. Vet Rec 1989;124:89-90.
6. Yovich JV, et al.: Effects of polysulphated glycosaminoglycan on chemical and physical defects in equine articular cartilage. Am J Vet Res 1987; 48(9):1407-1414
7. Trotter GW, et al.: Effects of intramuscular polysulphated glycosaminoglycan on chemical and physical defects in equine articular cartilage. Can J Vet Res 1989;53:224-230
8. Glade MJ: Polysulphated glycosaminoglycan accelerates net synthesis of collagen and glycosaminoglycans by arthritic equine cartilage tissues and chondrocytes. Am J Vet Res 1990;51(5): 779-785.
9. Schacterle & Pollack: Ann. Biochem 1973;51:654-655.
10. Dacie JV: Practical Haematology NY: Grune and Strantton.
11. Cheney M: AAEP Proceedings 1996:42,pp 69-74.
12. Barr ARS, et al.: Influence of intraarticular sodium hyaluronate and polysulphated glycosaminoglycans on the biochemical composition of equine articular surface repair tissue. Equine Veterinary Journal 1994;26(1):40-42.
13. Caron JP, et al.: AAEP 1984;pp 137-138.
14. Videla Dorna et al.: AAVE Annual Convention, San Isidro, Buenos Aires Argentina.1994.
15. Hamm D, Jones EW: Intra-articular (IA) and intramuscular (MI) treatment of noninfectious equine arthritis (DJD) with polysulphated glycosaminoglycan (PSGAG), J of Equine Veterinary Science 1988;8:(6)456-459.
16. Diaz VB, et al.: Chondroitin Sulfate (Overview) in Polymeric Materials Encyclopedia. Vol. 2c CRC Press Ed. Joseph C. Salamone 1996.
17. McIlwraith W, Trotter GW: Joint disease in the horse, W.B. Saunders Company. Ed. 1996;pp:421-440.
18. Palmieri L, et al.: Metabolic fate of exogenus chondroitin sulfate in experimental animal. Arzneim. Forsch./Drug Res 1990;40(l)3:319-323.
19. Conte A, et al.: Metabolic rate of exogenus chondroitin sulfate in man. Arzneim. Forsch/Drug Res 1991;41(ll)7: 768-772.
20. Pipitone VR: Chondroprotection with chondroitin sulfate. Drugs Expl. Clin Res 1991;XVII(1):3-7.
21. White GW, et al.: The efficacy of orally administered sulfated glycosaminoglycan in chemically induced equine synovitis and degenerative joint disease. Journal Equine Veterinary Science 1994;14(7):350-353.
22. Leeb BF, et al.: Results of a multicenter study of chondroitin sulfate (Condrosulf) use in arthroses of the finger, knee and hip joints. Wten Med Wochenschr, 1996;146(24):609-614.